Back

Relative fat mass (RFM) is a better predictor of dyslipidemia and metabolic syndrome than body mass index (BMI).

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Lipids Cardiovascular Risk Assessment ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ofer Kobo

Hillel Yaffe Medical Center, Hadera (Israel)

14 More presentations in this session

Presentation thumbnail
Professor E. Bruckert (Paris, FR)
Abstract Slides
Presentation thumbnail
Doctor A. Endo (Izumo, JP)
Abstract
Presentation thumbnail
Professor I. Ahrens (Cologne, DE)
Abstract
Presentation thumbnail
Professor K. Sung (Seoul, KR)
Abstract
Presentation thumbnail
Ms N. Jaspers (Utrecht, NL)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Lipids

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Established and novel adiposity measures and their association with incident atrial fibrillation, heart failure and ischaemic heart disease in the general population
23 May 2022
thumbnail
Congress Session
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
18 May 2025
thumbnail
Congress Presentation
Relationship between blood lipid panel with body mass, smoke exposure, dyspnea, physical activity, and quality of life in patients with dyslipidemia
26 April 2024
thumbnail
Congress Presentation
Lean metabolic syndrome is associated with similar long-term prognosis as metabolic syndrome in overweight/obese patients. Analysis 47 399 Patients from nationwide LIPIDOGRAM 2004-2015 cohort studies.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources